Cooke & Bieler LP Has $251.33 Million Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Cooke & Bieler LP increased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 18.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,061,910 shares of the medical instruments supplier’s stock after acquiring an additional 1,092,922 shares during the quarter. DENTSPLY SIRONA comprises about 2.2% of Cooke & Bieler LP’s investment portfolio, making the stock its 7th biggest holding. Cooke & Bieler LP owned about 3.33% of DENTSPLY SIRONA worth $251,333,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Wellington Management Group LLP increased its stake in DENTSPLY SIRONA by 83.1% during the 1st quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock valued at $270,829,000 after purchasing an additional 2,497,773 shares in the last quarter. Norges Bank bought a new stake in DENTSPLY SIRONA during the 4th quarter valued at about $60,861,000. Lazard Asset Management LLC increased its stake in DENTSPLY SIRONA by 85.0% during the 4th quarter. Lazard Asset Management LLC now owns 2,992,857 shares of the medical instruments supplier’s stock valued at $95,292,000 after purchasing an additional 1,375,285 shares in the last quarter. Price T Rowe Associates Inc. MD increased its stake in DENTSPLY SIRONA by 18.6% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 7,802,326 shares of the medical instruments supplier’s stock valued at $306,476,000 after purchasing an additional 1,224,984 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. increased its stake in DENTSPLY SIRONA by 25.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 5,083,334 shares of the medical instruments supplier’s stock valued at $161,854,000 after purchasing an additional 1,030,275 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Trading Up 0.2 %

XRAY opened at $30.50 on Friday. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The company’s 50 day moving average is $32.79 and its 200 day moving average is $32.84. DENTSPLY SIRONA Inc. has a 12-month low of $26.27 and a 12-month high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.01. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $972.61 million. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The firm’s revenue was up 3.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.46 earnings per share. As a group, equities analysts expect that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Wednesday, March 27th. This represents a $0.64 annualized dividend and a yield of 2.10%. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s payout ratio is currently -103.22%.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on XRAY shares. SVB Leerink started coverage on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective for the company. Leerink Partnrs reaffirmed an “outperform” rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Needham & Company LLC reaffirmed a “buy” rating and set a $42.00 price target on shares of DENTSPLY SIRONA in a report on Thursday, February 29th. Piper Sandler raised their price target on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the company a “neutral” rating in a report on Friday, January 12th. Finally, StockNews.com raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, January 19th. Three analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $39.50.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.